Leyden Labs raised €124M in a Series B round in Jan 2022. The company is based in Amsterdam, Netherlands. Investors in the round: Bluebird Ventures, Byers Capital, Casdin Capital and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
